Zenith Health Care has reappointed Mrs. Neela M. Raycha as a Non-Executive Director following her retirement by rotation. The appointment was confirmed in a disclosure to the BSE on August 31, 2026.

Mrs. Raycha, who first joined the board on March 13, 2001, offers herself for re-appointment pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. She holds a B.Sc. and L.L.B., with specific expertise in quality control and product development.

Director Profile

Mrs. Raycha serves as the spouse of the Company’s Managing Director and the mother of the Joint Managing Director and Whole-time Director. She currently holds a directorship in Ray Remedies Private Limited but has no other memberships or chairmanships in public companies.

Her shareholding in Zenith Health Care stands at 1,261,712 equity shares. The company confirmed that she is not debarred from holding the office of director by any order passed by SEBI or any other authority.

The re-appointment will be considered at the company’s 32nd Annual General Meeting.

Zenith Health Care shareholders approved all five resolutions at its 32nd Annual General Meeting held on August 28, 2026. The approvals included the adoption of audited financials for FY26 and key management re-appointments. Notably, promoter votes were invalidated for the material related-party transaction with Achyut Healthcare Limited.

The meeting, conducted via video conferencing from 10:30 am to 10:44 am, saw participation from 39 members, comprising 10 promoters and 29 public shareholders. The statutory auditors’ report and secretarial audit report were submitted without qualifications. As on the record date of August 21, 2026, the company had 38,922 shareholders.

Governance and Management Changes

The board secured shareholder approval for several governance-related resolutions:

• Re-appointment of Mrs. Neela M. Raycha as a director, replacing her term that expired by rotation.
• Re-appointment of Mr. Mahendra C. Raycha as Managing Director for a three-year period from July 1, 2026, to June 30, 2029.
• Regularization of Mr. Akshit M. Raycha’s appointment as Joint Managing Director/Whole Time Director.

These appointments ensure continuity in the company’s leadership structure for the upcoming fiscal year.

Details on Mahendra C. Raycha’s Re-appointment

Mr. Mahendra C. Raycha (DIN: 00577647) was re-appointed as Managing Director by way of special resolution. The early re-appointment was necessitated because he attained the age of 70 years, requiring a fresh special resolution under Section 196 of the Companies Act.

Mr. Raycha is a Chartered Accountant with over 20 years of experience as Managing Director of the company without any break. He holds 6,604,000 equity shares, constituting 12.29% voting power. His monthly remuneration is capped at ₹2,00,000, payable as per the company’s financial convenience. He also holds directorships in Zenith Lifecare Private Limited, Zenith Medicine Private Limited, Ray Remedies Private Limited, and Achyut Healthcare Limited.

Related Party Transaction

Shareholders approved a material related-party transaction with Achyut Healthcare Limited via a special resolution. Pursuant to Section 188 of the Companies Act, 2013, votes cast by promoters, directors, KMPs, and their relatives were treated as invalid. Consequently, 1,52,47,762 votes were declared invalid for this resolution. The resolution passed with 99.95% of valid votes in favor.

Voting Results Overview

The following table summarizes the voting outcomes for the five resolutions placed before shareholders:

All resolutions were passed with the requisite majority. Remote e-voting was conducted through NSDL from August 25 to August 27, 2026. M/s Kamlesh M. Shah served as the scrutinizer for the process.